<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02883569</url>
  </required_header>
  <id_info>
    <org_study_id>LBP</org_study_id>
    <nct_id>NCT02883569</nct_id>
  </id_info>
  <brief_title>Comparative Effectiveness Study for Surgery vs. Non-Surgery in Patients With Low Back Pain</brief_title>
  <acronym>CES_SNS_LBP</acronym>
  <official_title>Randomized Control Trial. Comparative Effectiveness Study for Surgery vs. Non-Surgery in Patients With Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gangnam Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea University Guro Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: Comparative effectiveness research (CER) between surgical and non-surgical treatment&#xD;
      for patients with low back pain Hypothesis: There will be significant differences in surgical&#xD;
      and non-surgical treatment effect in patients who need operation for herniated intervertebral&#xD;
      disc and spinal stenosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Eighty percents of the total population experiences lower back pain (LBP).&#xD;
      Prevalence of LBP is about 20 to 30%. LBP is the most frequent disease and causes a lot of&#xD;
      the medical and social costs. Recently the traditional drug therapy, exercise therapy has&#xD;
      been developed and various non-surgical treatments have been developed. Surgical techniques&#xD;
      are also rapidly evolving. In Korea lumbar spine surgeries were performed in accordance with&#xD;
      the national practice guidelines presented by the Health Insurance Review and Assessment&#xD;
      Service. Many patients who do not meet the surgical criteria undergo the non-surgical&#xD;
      treatment, but there is no reliable research data for a systematic and cost-effective results&#xD;
      of non-surgical treatment. It will be a big part of the future medical expenses because there&#xD;
      is no guideline for the expensive procedure.&#xD;
&#xD;
      Contents:&#xD;
&#xD;
        1. Prospective randomized controlled trials to evaluate effectiveness and efficacy between&#xD;
           surgical vs. non-surgical treatment for optimal treatment of low back pain&#xD;
&#xD;
        2. Prospective observational clinical study for non-surgical treatment methods&#xD;
&#xD;
        3. Analysis of health insurance data&#xD;
&#xD;
        4. Comprehensive symposium&#xD;
&#xD;
        5. Provide guideline for optimal treatment of low back pain&#xD;
&#xD;
        6. The results will be used to reflect National health insurance policy Development&#xD;
           Results: Suggestion of guideline for optimal treatment of low back pain through analysis&#xD;
           of efficacy and effectiveness between treatments&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the change of pain score after treatment</measure>
    <time_frame>baseline and 24 months after treatment.</time_frame>
    <description>Visual analog scale (VAS) is decresed more than 2.5 or VAS is less than 3.5.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Appropriate conservative treatment period</measure>
    <time_frame>1, 3, 6, 12, 24 months after treatment.</time_frame>
    <description>Appropriate conservative treatment period, Cost-effectiveness analysis (Quality of life index (SF-36, EQ-5D-5L), Direct medical cost)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the change of pain score (Visual anlogue pain score) after time of treatment</measure>
    <time_frame>1, 3, 6, 12, 24 months after treatment.</time_frame>
    <description>compare the trend of change with mixed-model</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>24 month after treatment</time_frame>
    <description>Compare direct cost after each treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life index (SF-36)</measure>
    <time_frame>1, 3, 6, 12, 24 months after treatment.</time_frame>
    <description>compare the trend of change with mixed-model</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life index (EQ-5D-5L)</measure>
    <time_frame>1, 3, 6, 12, 24 months after treatment.</time_frame>
    <description>compare the trend of change with mixed-model</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">1102</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>HIVD-OP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>open or endoscopic discectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIVD-NonOP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>epidural block, epidural adhesiolysis, exercise, ibuprofen, naxoprofen, Cox-2 inhibitor, aceclofenac, codeine, oxycontine, IRcodone, Tramadol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LSS w/o instability -OP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>decompression, instrumentation and fusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LSS w/o instability -NonOP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>epidural block, epidural adhesiolysis, exercise, ibuprofen, naxoprofen, Cox-2 inhibitor, aceclofenac, codeine, oxycontine, IRcodone, Tramadol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LSS w/ instability - OP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>decompression, instrumentation and fusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LSS w/ instability - NonOP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>epidural block, epidural adhesiolysis, exercise, ibuprofen, naxoprofen, Cox-2 inhibitor, aceclofenac, codeine, oxycontine, IRcodone, Tramadol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>exercise, ibuprofen, naxoprofen, Cox-2 inhibitor, aceclofenac, codeine, oxycontine, IRcodone, Tramadol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>epidural block, epidural adhesiolysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>open or endoscopic discectomy</intervention_name>
    <description>FDA approved surgical procedures</description>
    <arm_group_label>HIVD-OP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>epidural block</intervention_name>
    <description>epidural block</description>
    <arm_group_label>HIVD-NonOP</arm_group_label>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_label>LSS w/ instability - NonOP</arm_group_label>
    <arm_group_label>LSS w/o instability -NonOP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>exercise</intervention_name>
    <description>educated exercise</description>
    <arm_group_label>HIVD-NonOP</arm_group_label>
    <arm_group_label>LSS w/ instability - NonOP</arm_group_label>
    <arm_group_label>LSS w/o instability -NonOP</arm_group_label>
    <arm_group_label>No intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ibuprofen, naxoprofen, Cox-2 inhibitor, aceclofenac</intervention_name>
    <description>FDA approved medication such as ibuprofen, naxoprofen etc.</description>
    <arm_group_label>HIVD-NonOP</arm_group_label>
    <arm_group_label>LSS w/ instability - NonOP</arm_group_label>
    <arm_group_label>LSS w/o instability -NonOP</arm_group_label>
    <arm_group_label>No intervention group</arm_group_label>
    <other_name>NSAID</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>decompression</intervention_name>
    <description>FDA approved surgical procedure such as lamiectom and, laminotomy</description>
    <arm_group_label>HIVD-OP</arm_group_label>
    <arm_group_label>LSS w/ instability - OP</arm_group_label>
    <arm_group_label>LSS w/o instability -OP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>instrumentation and fusion</intervention_name>
    <description>FDA approved surgical procedure such as PLIF, ALIF, DLIF, OLI and TLIF</description>
    <arm_group_label>HIVD-OP</arm_group_label>
    <arm_group_label>LSS w/ instability - OP</arm_group_label>
    <arm_group_label>LSS w/o instability -OP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>codeine, oxycontine, IRcodone, Tramadol</intervention_name>
    <description>FDA approved opioid drug such as codeine, oxycontin, IRcodon</description>
    <arm_group_label>HIVD-NonOP</arm_group_label>
    <arm_group_label>LSS w/ instability - NonOP</arm_group_label>
    <arm_group_label>LSS w/o instability -NonOP</arm_group_label>
    <arm_group_label>No intervention group</arm_group_label>
    <other_name>opioid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>epidural adhesiolysis</intervention_name>
    <description>FDA approved epidural adhesiolysis with catheter or endoscope</description>
    <arm_group_label>HIVD-NonOP</arm_group_label>
    <arm_group_label>LSS w/ instability - NonOP</arm_group_label>
    <arm_group_label>LSS w/o instability -NonOP</arm_group_label>
    <arm_group_label>No intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Herniated intervertebral disease, Low back pain over 6 weeks: if neurological deficit&#xD;
             is combined early surgery is allowed; Over 18 years; Visual analogue pain score over&#xD;
             5; Compatible findings in MRI and/or CT&#xD;
&#xD;
          2. Lumbar spinal stenosis without instability, Low back pain over 3 months: if&#xD;
             neurological deficit is combined early surgery is allowed; Over 18 years; Visual&#xD;
             analogue pain score over 5; Compatible findings in MRI and/or CT; Without instability&#xD;
             (15 degrees and 4mm motion)&#xD;
&#xD;
          3. Lumbar spinal stenosis with instability, Low back pain over 3 months: if neurological&#xD;
             deficit is combined early surgery is allowed; Over 18 years; Visual analogue pain&#xD;
             score over 5; Compatible findings in MRI and/or CT; With instability (15 degrees and&#xD;
             4mm motion)&#xD;
&#xD;
          4. No surgical indication, Low back pain over 6 weeks: if neurological deficit is&#xD;
             combined early surgery is allowed; Over 18 years; Visual analogue pain score over 5;&#xD;
             Compatible findings in MRI and/or CT;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Herniated intervertebral disease, Cauda equine syndrome; Instability (15degrees, 4mm&#xD;
             motion); Fracture, pregnancy; Any comorbidities that preclude operation; Combined&#xD;
             disease: Neuromuscular disease, parkinson's disease, inflammatory arthritis,&#xD;
             symptomatic spinal tumor, myelopathy, spinal infection; Previous lumbar spinal&#xD;
             surgery; Neurological deficit that necessitates surgery&#xD;
&#xD;
          2. Lumbar spinal stenosis without instability, Cauda equine syndrome; Instability&#xD;
             (15degrees, 4mm motion); Fracture, pregnancy Any comorbidities that preclude&#xD;
             operation; Combined disease: Neuromuscular disease, parkinson's disease, inflammatory&#xD;
             arthritis, symptomatic spinal tumor, myelopathy, spinal infection; Previous lumbar&#xD;
             spinal surgery; Neurological deficit that necessitates surgery&#xD;
&#xD;
          3. Lumbar spinal stenosis with instability, Cauda equine syndrome; Fracture, pregnancy;&#xD;
             Any comorbidities that preclude operation; Combined disease: Neuromuscular disease,&#xD;
             parkinson's disease, inflammatory arthritis, symptomatic spinal tumor, myelopathy,&#xD;
             spinal infection Previous lumbar spinal surgery; Neurological deficit that&#xD;
             necessitates surgery&#xD;
&#xD;
          4. No surgical indication, Cauda equine syndrome; Fracture, pregnancy; Combined disease:&#xD;
             Neuromuscular disease, parkinson's disease, inflammatory arthritis, symptomatic spinal&#xD;
             tumor, myelopathy, spinal infection; Neurological deficit that necessitates surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chun Kee Chung, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>July 25, 2016</study_first_submitted>
  <study_first_submitted_qc>August 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2016</study_first_posted>
  <last_update_submitted>August 25, 2020</last_update_submitted>
  <last_update_submitted_qc>August 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Chun Kee Chung</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Low back pain</keyword>
  <keyword>Intervertebral Disc Degeneration</keyword>
  <keyword>Spinal stenosis</keyword>
  <keyword>Comparative Effectiveness Research</keyword>
  <keyword>Cost-Benefit Analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Aceclofenac</mesh_term>
    <mesh_term>Cyclooxygenase 2 Inhibitors</mesh_term>
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Codeine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

